Related Experiment Video
Updated: Jun 21, 2026

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
Published on: August 9, 2022
[Progress in the research of amorphous pharmaceuticals]
Jian Ying1, Yang Lü, Guan-hua Du
1Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Amorphous solid dispersions offer enhanced drug bioavailability and absorption compared to crystalline forms. However, challenges like instability and potential adverse reactions require careful consideration in pharmaceutical development.
Area of Science:
- Solid-state chemistry
- Materials science
- Pharmaceutical sciences
Context:
- Amorphous solid dispersions represent a unique physical state of compounds lacking long-range molecular order.
- These materials are increasingly researched for their potential to improve drug delivery and therapeutic outcomes.
- Understanding their properties is crucial for pharmaceutical innovation.
Purpose:
- To review recent advancements in amorphous pharmaceutical compounds.
- To summarize factors influencing the efficacy of amorphous pharmaceuticals.
- To discuss the future prospects of amorphous techniques in the pharmaceutical industry.
Summary:
- Amorphous compounds, characterized by disordered molecular or atomic arrangements, can exhibit superior bioavailability and absorption rates compared to their crystalline (amorphous) counterparts.
- This enhanced performance is particularly relevant for acute and intermittent symptoms, potentially altering drug efficacy.
- Pharmaceutical preparation methods significantly influence the final characteristics of amorphous compounds.
- Despite their advantages, challenges such as instability and the risk of adverse drug reactions necessitate thorough investigation.
Impact:
- Highlights the therapeutic potential of amorphous solid dispersions in drug formulation.
- Identifies key factors and challenges for optimizing amorphous pharmaceutical development.
- Provides insights into the future direction of amorphous technologies in pharmaceutical research and industry.
Related Concept Videos
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Polymer Classification: Crystallinity
Crystalline domains are the regions where polymer chains are aligned in an orderly manner and held together in proximity by intermolecular forces. For example, chains in the crystalline domains of polyethylene and nylon are bound together by van der Waals...
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Drug Discovery: Overview
Factors Influencing Drug Absorption: Physicochemical Parameters
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
